celiac < cell < cells

Facettes :

List of bibliographic references indexed by cell

Number of relevant bibliographic references: 44.
[0-20] [0 - 20][0 - 44][20-40]

Ident.	Authors (with country if any)	Title
000063 (2015)	Björn Br Ndl [Allemagne] ; Susanne A. Schneider ; Jeanne F. Loring ; John Hardy ; Philip Gribbon ; Franz-Josef Müller	Stem cell reprogramming: basic implications and future perspective for movement disorders.
000192 (2015)	C Warren Olanow [États-Unis]	Levodopa: effect on cell death and the natural history of Parkinson's disease.
000286 (2015)	Nathan C. Rowland [États-Unis] ; Philip A. Starr ; Paul S. Larson ; Jill L. Ostrem ; William J. Marks ; Daniel A. Lim	Combining cell transplants or gene therapy with deep brain stimulation for Parkinson's disease.
000417 (2014)	Anne Rosser [Royaume-Uni] ; Clive N. Svendsen	Stem cells for cell replacement therapy: a therapeutic strategy for HD?
000436 (2014)	Holly A. Shill [États-Unis] ; Charles H. Adler ; Joseph G. Hentz	Reply: Purkinje cell loss in essential tremor.
000457 (2014)	Elan D. Louis [États-Unis] ; Phyllis L. Faust [États-Unis]	Purkinje Cell Loss in Essential Tremor
000589 (2014)	Claire Symanski [États-Unis] ; Holly A. Shill ; Brittany Dugger ; Joseph G. Hentz ; Charles H. Adler ; Sandra A. Jacobson ; Erika Driver-Dunckley ; Thomas G. Beach	Essential tremor is not associated with cerebellar Purkinje cell loss.
000618 (2014)	Julia Kraemmer [Autriche] ; Gabor G. Kovacs ; Laura Perju-Dumbrava ; Susanne Pirker ; Tatiana Traub-Weidinger ; Walter Pirker	Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts.
000818 (2013)	Elan D. Louis [États-Unis] ; Rachel Babij [États-Unis] ; Michelle Lee [États-Unis] ; Etty Cortés [États-Unis] ; Jean-Paul G. Vonsattel [États-Unis]	Quantification of Cerebellar Hemispheric Purkinje Cell Linear Density: 32 ET Cases vs. 16 Controls
000977 (2013)	Ryosuke Takahashi [Japon] ; Hodaka Yamakado	Genetic correction will be a standard method for the patient-derived ips cell research?
000A31 (2013)	Olle Lindvall [Suède]	Developing dopaminergic cell therapy for Parkinson's disease--give up or move forward?
000A76 (2013)	Anders Bjorklund [Suède] ; Jeffrey H. Kordower	Cell therapy for Parkinson's disease: what next?
000B12 (2013)	Mathieu Bourdenx [France]	Allograft of stem cell-derived dopaminergic neurons for Parkinson's disease.
000D17 (2012)	Michel Engeln [France]	Mechanisms for preferential dopaminergic cell loss induced by alpha-synuclein.
000D42 (2012)	Alexander Storch [Allemagne] ; Ilona Csoti ; Karla Eggert ; Tove Henriksen ; Annika Plate ; Michael Lorrain ; Wolfgang H. Oertel ; Angelo Antonini	Intrathecal application of autologous bone marrow cell preparations in Parkinsonian syndromes.
000D51 (2012)	Susan H. Fox [Canada]	Improved viability of stem cell transplants in animal models of Parkinson's disease.
000E89 (2012)	Ralf Reilmann [Allemagne]	An important step towards translation of stem cell therapies in clinical applications for neurodegenerative diseases and beyond?
001083 (2012)	Alexander Storch [Allemagne] ; Ilona Csoti [Allemagne] ; Karla Eggert [Allemagne] ; Tove Henriksen [Danemark] ; Annika Plate [Allemagne] ; Michael Lorrain [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Angelo Antonini [Italie]	Intrathecal Application of Autologous Bone Marrow Cell Preparations in Parkinsonian Syndromes
001501 (2011)	Elias S. Sotirchos [Grèce] ; E. Ray Dorsey [États-Unis] ; Ik Lin Tan [États-Unis] ; David S. Zee [États-Unis]	Opsoclonus‐myoclonus syndrome and exaggerated startle response associated with small‐cell lung cancer
001579 (2011)	Elisa Garbayo [Espagne] ; Eduardo Ansorena [Espagne] ; Jose Luis Lanciego [Espagne] ; María Jose Blanco-Prieto [Espagne] ; María S. Aymerich [Espagne]	Long‐term neuroprotection and neurorestoration by glial cell‐derived neurotrophic factor microspheres for the treatment of Parkinson's disease
001838 (2011)	Jin-Chong Xu [États-Unis] ; Ted M. Dawson [États-Unis]	A perfect “Match” for in vitro human disease modeling and autologous cell‐based transplantation therapy: Generating genetically identical Parkinson's disease and control pluripotent stem cells by precise gene targeting

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "cell" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "cell" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    cell
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024